peptide,lca,superkingdom,kingdom,subkingdom,superphylum,phylum,subphylum,superclass,class,subclass,infraclass,superorder,order,suborder,infraorder,parvorder,superfamily,family,subfamily,tribe,subtribe,genus,subgenus,species group,species subgroup,species,subspecies,varietas,forma,EC,EC - names,GO (cellular component),GO (molecular function),GO (biological process),GO (cellular component) - names,GO (molecular function) - names,GO (biological process) - names,InterPro,InterPro - names
LSSPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (11%);GO:0016021 (2%),extracellular space (11%);integral component of membrane (2%),GO:0004252 (100%);GO:0046872 (4%),serine-type endopeptidase activity (100%);metal ion binding (4%),GO:0006508 (11%);GO:0007586 (4%),proteolysis (11%);digestion (4%),IPR001254 (100%);IPR009003 (100%);IPR043504 (100%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1, PA clan, chymotrypsin-like fold (100%)
YLYELAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.35 (57%);2.5.1.7 (14%);2.7.13.3 (14%),Pyridoxal kinase (57%);UDP-N-acetylglucosamine 1-carboxyvinyltransferase (14%);Histidine kinase (14%),GO:0005615 (86%);GO:0005737 (19%);GO:0032991 (9%),extracellular space (86%);cytoplasm (19%);protein-containing complex (9%),GO:0046872 (43%);GO:0005504 (14%);GO:0003677 (9%),metal ion binding (43%);fatty acid binding (14%);DNA binding (9%),GO:0001542 (13%);GO:0042448 (13%);GO:0060395 (13%),ovulation from ovarian follicle (13%);progesterone metabolic process (13%);SMAD protein signal transduction (13%),IPR000264 (90%);IPR014760 (90%);IPR020858 (90%),ALB/AFP/VDB (90%);Serum albumin, N-terminal (90%);Serum albumin-like (90%)
VATVSPLR,Solirubrobacteraceae,Bacteria,,,,Actinobacteria,,,Thermoleophilia,,,Solirubrobacterales,,,,Solirubrobacteraceae,,,,,,,,,,,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),,,,,IPR003838 (100%);IPR025857 (100%),ABC3 transporter permease protein domain (100%);MacB-like periplasmic core domain (100%)
VAEVSLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVTVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (100%);GO:0008134 (100%);GO:0043565 (100%),ATP binding (100%);transcription factor binding (100%);sequence-specific DNA binding (100%),GO:0000160 (100%);GO:0006355 (100%),phosphorelay signal transduction system (100%);regulation of transcription, DNA-templated (100%),IPR001789 (100%);IPR002078 (100%);IPR002197 (100%),Signal transduction response regulator, receiver domain (100%);RNA polymerase sigma factor 54 interaction domain (100%);DNA binding HTH domain,  Fis-type (100%)
VVTVLSPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0007165 (100%),signal transduction (100%),IPR000157 (100%);IPR035897 (100%),Toll/interleukin-1 receptor homology (TIR) domain (100%);Toll/interleukin-1 receptor homology (TIR) domain superfamily (100%)
LATVLSPR,Gammaproteobacteria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR002634 (100%);IPR036065 (100%),BolA protein (100%);BolA-like superfamily (100%)
LSSLSVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.3.1 (75%);2.7.9.2 (25%),Sarcosine oxidase (75%);Pyruvate, water dikinase (25%),GO:0005737 (60%);GO:0031463 (20%),cytoplasm (60%);Cul3-RING ubiquitin ligase complex (20%),GO:0008115 (60%);GO:0005524 (20%);GO:0008986 (20%),sarcosine oxidase activity (60%);ATP binding (20%);pyruvate, water dikinase activity (20%),GO:0046653 (60%);GO:0006090 (20%);GO:0006094 (20%),tetrahydrofolate metabolic process (60%);pyruvate metabolic process (20%);gluconeogenesis (20%),IPR006222 (50%);IPR006277 (50%);IPR013977 (50%),Aminomethyltransferase, folate-binding domain (50%);Sarcosine oxidase, alpha subunit (50%);Glycine cleavage T-protein, C-terminal barrel domain (50%)
MVLNAAVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLDAAPHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVVNLGSGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPGVSLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSVNLGGSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NQYLSWVVEVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSPATTPGSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VSGWGNTR,Petromyzon marinus,Eukaryota,Metazoa,,,Chordata,Craniata,,Hyperoartia,,,Petromyzontiformes,,,,Petromyzontidae,,,,Petromyzon,,,,Petromyzon marinus,,,,,,,,,,GO:0004252 (100%),serine-type endopeptidase activity (100%),,,IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
HMMPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGPVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0051301 (80%),cell division (80%),IPR001182 (100%),Probable peptidoglycan glycosyltransferase FtsW/RodA (100%)
QPMHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPWLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.11.8 (43%);1.10.3.- (29%);3.1.4.3 (14%),Trimethyllysine dioxygenase (43%);With oxygen as acceptor (29%);Phospholipase C (14%),GO:0016021 (60%);GO:0005886 (5%);GO:0031011 (3%),integral component of membrane (60%);plasma membrane (5%);Ino80 complex (3%),GO:0008137 (22%);GO:0005524 (14%);GO:0004672 (13%),NADH dehydrogenase (ubiquinone) activity (22%);ATP binding (14%);protein kinase activity (13%),GO:0042773 (22%);GO:0045329 (4%);GO:0006779 (3%),ATP synthesis coupled electron transport (22%);carnitine biosynthetic process (4%);porphyrin-containing compound biosynthetic process (3%),IPR001750 (18%);IPR003918 (18%);IPR010227 (17%),NADH:quinone oxidoreductase/Mrp antiporter, membrane subunit (18%);NADH:ubiquinone oxidoreductase (18%);NADH-quinone oxidoreductase, chain M/4 (17%)
QRPMHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMEVHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNMTQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.14 (64%);2.7.7.6 (14%);1.8.4.11 (7%),Glycine--tRNA ligase (64%);DNA-directed RNA polymerase (14%);Peptide-methionine (S)-S-oxide reductase (7%),GO:0005737 (41%);GO:0016021 (7%);GO:0000502 (4%),cytoplasm (41%);integral component of membrane (7%);proteasome complex (4%),GO:0003677 (41%);GO:0005524 (37%);GO:0004820 (33%),DNA binding (41%);ATP binding (37%);glycine-tRNA ligase activity (33%),GO:0006426 (33%);GO:0006351 (7%);GO:0009405 (7%),glycyl-tRNA aminoacylation (33%);transcription, DNA-templated (7%);obsolete pathogenesis (7%),IPR002315 (33%);IPR004154 (33%);IPR006195 (33%),Glycyl-tRNA synthetase (33%);Anticodon-binding (33%);Aminoacyl-tRNA synthetase, class II (33%)
YLSWWEER,Marchantia polymorpha,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Marchantiopsida,Marchantiidae,,Marchantiales,,,,Marchantiaceae,,,,Marchantia,,,,Marchantia polymorpha,,,,,,,,,,GO:0005524 (100%);GO:0030983 (100%);GO:0004674 (50%),ATP binding (100%);mismatched DNA binding (100%);protein serine/threonine kinase activity (50%),GO:0006298 (100%),mismatch repair (100%),IPR000432 (100%);IPR007695 (100%);IPR016151 (100%),DNA mismatch repair protein MutS, C-terminal (100%);DNA mismatch repair protein MutS-like, N-terminal (100%);DNA mismatch repair protein MutS, N-terminal (100%)
MHLMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YWYHLFLVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYYHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNHMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EHFVHLTATNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAPLVGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.3.1 (33%);2.4.2.28 (33%);3.6.4.12 (33%),Sarcosine oxidase (33%);S-methyl-5'-thioadenosine phosphorylase (33%);DNA helicase (33%),GO:0016020 (28%);GO:0016021 (12%);GO:0005634 (4%),membrane (28%);integral component of membrane (12%);nucleus (4%),GO:0016651 (28%);GO:0051539 (28%);GO:0004519 (24%),oxidoreductase activity, acting on NAD(P)H (28%);4 iron, 4 sulfur cluster binding (28%);endonuclease activity (24%),GO:0016539 (24%);GO:0006559 (16%);GO:0006570 (16%),intein-mediated protein splicing (24%);L-phenylalanine catabolic process (16%);tyrosine metabolic process (16%),IPR010226 (28%);IPR017896 (28%);IPR017900 (28%),NADH-quinone oxidoreductase, chain I (28%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (28%);4Fe-4S ferredoxin, iron-sulphur binding, conserved site (28%)
WYYHLTANTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHLMHLTASK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GGSGGSYGGGGSGGGYGGGSGSR,Hominoidea,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Hominoidea,,,,,,,,,,,,,,,,,GO:0005882 (100%);GO:0005615 (14%);GO:0005634 (14%),intermediate filament (100%);extracellular space (14%);nucleus (14%),GO:0005198 (86%);GO:0005200 (14%),structural molecule activity (86%);structural constituent of cytoskeleton (14%),GO:0007283 (57%);GO:0043588 (57%);GO:0045109 (57%),spermatogenesis (57%);skin development (57%);intermediate filament organization (57%),IPR002957 (100%);IPR018039 (100%);IPR039008 (100%),Keratin, type I (100%);Intermediate filament protein, conserved site (100%);Intermediate filament, rod domain (100%)
FSSSSGYGGGSSR,Euarchontoglires,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,Euarchontoglires,,,,,,,,,,,,,,,,,,,,,GO:0005882 (100%);GO:0005615 (6%);GO:0005634 (6%),intermediate filament (100%);extracellular space (6%);nucleus (6%),GO:0005198 (94%);GO:0005200 (6%),structural molecule activity (94%);structural constituent of cytoskeleton (6%),GO:0043588 (78%);GO:0045109 (78%);GO:0007283 (61%),skin development (78%);intermediate filament organization (78%);spermatogenesis (61%),IPR002957 (100%);IPR039008 (100%);IPR042180 (100%),Keratin, type I (100%);Intermediate filament, rod domain (100%); (100%)
VLEGNEQFLNAAK,Simiiformes,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (15%);GO:0005576 (4%);GO:1904724 (4%),extracellular space (15%);extracellular region (4%);tertiary granule lumen (4%),GO:0004252 (100%);GO:0005509 (12%);GO:0008236 (4%),serine-type endopeptidase activity (100%);calcium ion binding (12%);serine-type peptidase activity (4%),GO:0006508 (12%);GO:0031638 (12%);GO:0043542 (12%),proteolysis (12%);zymogen activation (12%);endothelial cell migration (12%),IPR001254 (100%);IPR009003 (100%);IPR043504 (100%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1, PA clan, chymotrypsin-like fold (100%)
EGNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
STSSFSCLSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (97%);GO:0001533 (49%);GO:0005882 (5%),keratin filament (97%);cornified envelope (49%);intermediate filament (5%),GO:0008092 (49%);GO:0030280 (49%);GO:0005200 (3%),cytoskeletal protein binding (49%);structural constituent of skin epidermis (49%);structural constituent of cytoskeleton (3%),GO:0003334 (49%);GO:0018149 (49%);GO:0031424 (49%),keratinocyte development (49%);peptide cross-linking (49%);keratinization (49%),IPR032444 (100%);IPR039008 (100%);IPR042180 (100%),Keratin type II head (100%);Intermediate filament, rod domain (100%); (100%)
SLVNLGGSK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0005886 (61%);GO:0001533 (33%),keratin filament (100%);plasma membrane (61%);cornified envelope (33%),GO:0046982 (35%);GO:0030246 (33%);GO:0030280 (33%),protein heterodimerization activity (35%);carbohydrate binding (33%);structural constituent of skin epidermis (33%),GO:0051290 (35%);GO:0001867 (33%);GO:0018149 (33%),protein heterotetramerization (35%);complement activation, lectin pathway (33%);peptide cross-linking (33%),IPR003054 (100%);IPR032444 (100%);IPR039008 (100%),Keratin, type II (100%);Keratin type II head (100%);Intermediate filament, rod domain (100%)
SGGGGGGGLGSGGSLR,Hominidae,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Hominoidea,Hominidae,,,,,,,,,,,,,,,,GO:0005882 (100%);GO:0005615 (17%);GO:0005634 (17%),intermediate filament (100%);extracellular space (17%);nucleus (17%),GO:0005198 (83%);GO:0005200 (17%),structural molecule activity (83%);structural constituent of cytoskeleton (17%),GO:0043588 (83%);GO:0045109 (83%);GO:0007283 (67%),skin development (83%);intermediate filament organization (83%);spermatogenesis (67%),IPR002957 (100%);IPR039008 (100%);IPR042180 (100%),Keratin, type I (100%);Intermediate filament, rod domain (100%); (100%)
SLVGLGGTK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (98%);GO:0001533 (33%);GO:0005882 (3%),keratin filament (98%);cornified envelope (33%);intermediate filament (3%),GO:0008092 (33%);GO:0030280 (33%);GO:0005200 (2%),cytoskeletal protein binding (33%);structural constituent of skin epidermis (33%);structural constituent of cytoskeleton (2%),GO:0045684 (35%);GO:0003334 (33%);GO:0018149 (33%),positive regulation of epidermis development (35%);keratinocyte development (33%);peptide cross-linking (33%),IPR018039 (99%);IPR032444 (99%);IPR039008 (99%),Intermediate filament protein, conserved site (99%);Keratin type II head (99%);Intermediate filament, rod domain (99%)
LLTHPNFN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLDVLEGN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VATVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (29%),extracellular space (29%),GO:0004252 (100%);GO:0046872 (14%),serine-type endopeptidase activity (100%);metal ion binding (14%),GO:0006508 (29%);GO:0007586 (14%),proteolysis (29%);digestion (14%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
LASYLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (69%);1.2.1.88 (20%);4.6.1.12 (2%),DNA-directed DNA polymerase (69%);L-glutamate gamma-semialdehyde dehydrogenase (20%);2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (2%),GO:0005882 (90%);GO:0005737 (3%);GO:0071944 (3%),intermediate filament (90%);cytoplasm (3%);cell periphery (3%),GO:0005198 (88%);GO:0003677 (4%);GO:0000166 (3%),structural molecule activity (88%);DNA binding (4%);nucleotide binding (3%),GO:0002009 (4%);GO:0007568 (3%);GO:0042633 (3%),morphogenesis of an epithelium (4%);aging (3%);hair cycle (3%),IPR039008 (90%);IPR042180 (90%);IPR002957 (90%),Intermediate filament, rod domain (90%); (90%);Keratin, type I (90%)
LAADDFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.10 (33%);2.7.7.18 (33%);2.7.7.59 (33%),Aminomethyltransferase (33%);Nicotinate-nucleotide adenylyltransferase (33%);[Protein-PII] uridylyltransferase (33%),GO:0005882 (97%);GO:0045095 (2%);GO:0071944 (2%),intermediate filament (97%);keratin filament (2%);cell periphery (2%),GO:0005198 (96%);GO:0097110 (2%);GO:0030280 (1%),structural molecule activity (96%);scaffold protein binding (2%);structural constituent of skin epidermis (1%),GO:0007568 (2%);GO:0042633 (2%);GO:0031424 (2%),aging (2%);hair cycle (2%);keratinization (2%),IPR039008 (99%);IPR002957 (99%);IPR042180 (99%),Intermediate filament, rod domain (99%);Keratin, type I (99%); (99%)
QFSSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.10 (14%);2.6.1.- (8%);2.7.1.- (8%),Thiazole synthase (14%);Transaminases (8%);Phosphotransferases with an alcohol group as acceptor (8%),GO:0016021 (30%);GO:0005634 (10%);GO:0005886 (8%),integral component of membrane (30%);nucleus (10%);plasma membrane (8%),GO:0005524 (13%);GO:0003677 (8%);GO:0046872 (5%),ATP binding (13%);DNA binding (8%);metal ion binding (5%),GO:0006355 (5%);GO:0000160 (4%);GO:0009229 (3%),regulation of transcription, DNA-templated (5%);phosphorelay signal transduction system (4%);thiamine diphosphate biosynthetic process (3%),IPR013087 (8%);IPR036236 (8%);IPR027417 (5%),Zinc finger C2H2-type (8%);Zinc finger C2H2 superfamily (8%);P-loop containing nucleoside triphosphate hydrolase (5%)
SLSLSVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.5.1 (50%);3.5.99.2 (50%),Electron-transferring-flavoprotein dehydrogenase (50%);Aminopyrimidine aminohydrolase (50%),GO:0045095 (92%);GO:0005886 (47%);GO:0001533 (37%),keratin filament (92%);plasma membrane (47%);cornified envelope (37%),GO:0030280 (37%);GO:0046982 (36%);GO:0030246 (35%),structural constituent of skin epidermis (37%);protein heterodimerization activity (36%);carbohydrate binding (35%),GO:0018149 (37%);GO:0051290 (36%);GO:0001867 (35%),peptide cross-linking (37%);protein heterotetramerization (36%);complement activation, lectin pathway (35%),IPR032444 (92%);IPR003054 (91%);IPR039008 (91%),Keratin type II head (92%);Keratin, type II (91%);Intermediate filament, rod domain (91%)
VVTLVSPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (100%),membrane (100%),GO:0008137 (100%);GO:0051539 (100%),NADH dehydrogenase (ubiquinone) activity (100%);4 iron, 4 sulfur cluster binding (100%),GO:0042773 (100%),ATP synthesis coupled electron transport (100%),IPR000283 (100%);IPR001041 (100%);IPR006656 (100%),NADH:ubiquinone oxidoreductase, 75kDa subunit, conserved site (100%);2Fe-2S ferredoxin-type iron-sulfur binding domain (100%);Molybdopterin oxidoreductase (100%)
VAQVALLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.2.6 (100%),Hydroxyacylglutathione hydrolase (100%),GO:0005739 (33%);GO:0016021 (33%),mitochondrion (33%);integral component of membrane (33%),GO:0004416 (33%);GO:0008289 (33%);GO:0022857 (33%),hydroxyacylglutathione hydrolase activity (33%);lipid binding (33%);transmembrane transporter activity (33%),GO:0006744 (33%);GO:0019243 (33%),ubiquinone biosynthetic process (33%);methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (33%),IPR013877 (50%);IPR016024 (50%);IPR019516 (50%),YAP-binding/ALF4/Glomulin (50%);Armadillo-type fold (50%);Glomulin/ALF4 (50%)
NLSEAQLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.85 (100%),Diadenylate cyclase (100%),GO:0016021 (18%);GO:0005886 (14%);GO:0016459 (14%),integral component of membrane (18%);plasma membrane (14%);myosin complex (14%),GO:0003677 (55%);GO:0005524 (32%);GO:0004016 (18%),DNA binding (55%);ATP binding (32%);adenylate cyclase activity (18%),GO:0006171 (18%);GO:0019932 (18%);GO:0007165 (5%),cAMP biosynthetic process (18%);second-messenger-mediated signaling (18%);signal transduction (5%),IPR001647 (52%);IPR009057 (52%);IPR025996 (52%),DNA-binding HTH domain, TetR-type (52%);Homeobox-like domain superfamily (52%);Tetracyclin repressor-like, C-terminal domain (WHG) (52%)
EQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLDVL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVVDLNSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EESSLHAER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSGTAANTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLDLSGFK,Delftia,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,Burkholderiales,,,,Comamonadaceae,,,,Delftia,,,,,,,,,,,,,,GO:0030246 (100%);GO:0004180 (33%),carbohydrate binding (100%);carboxypeptidase activity (33%),,,IPR011050 (100%);IPR013783 (100%);IPR013784 (100%),Pectin lyase fold/virulence factor (100%);Immunoglobulin-like fold (100%);Carbohydrate-binding-like fold (100%)
SPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004252 (100%),serine-type endopeptidase activity (100%),,,IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
SSPATLNSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLGGGFGGGSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLDVLEG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.11 (97%);2.3.1.20 (1%);2.3.3.14 (1%),3-methyl-2-oxobutanoate hydroxymethyltransferase (97%);Diacylglycerol O-acyltransferase (1%);Homocitrate synthase (1%),GO:0005737 (74%);GO:0016021 (2%);GO:0005886 (1%),cytoplasm (74%);integral component of membrane (2%);plasma membrane (1%),GO:0046872 (86%);GO:0003864 (74%);GO:0008168 (72%),metal ion binding (86%);3-methyl-2-oxobutanoate hydroxymethyltransferase activity (74%);methyltransferase activity (72%),GO:0015940 (74%);GO:0032259 (72%);GO:0045892 (4%),pantothenate biosynthetic process (74%);methylation (72%);negative regulation of transcription, DNA-templated (4%),IPR003700 (73%);IPR015813 (73%);IPR040442 (73%),Ketopantoate hydroxymethyltransferase (73%);Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (73%);Pyruvate kinase-like domain superfamily (73%)
LVGGYTCAAN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLQYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.4 (57%);2.1.1.72 (14%);2.7.10.2 (14%),Tripeptide aminopeptidase (57%);Site-specific DNA-methyltransferase (adenine-specific) (14%);Non-specific protein-tyrosine kinase (14%),GO:0016021 (16%);GO:0005737 (13%);GO:0005886 (6%),integral component of membrane (16%);cytoplasm (13%);plasma membrane (6%),GO:0008168 (35%);GO:0008237 (13%);GO:0008270 (13%),methyltransferase activity (35%);metallopeptidase activity (13%);zinc ion binding (13%),GO:0032259 (35%);GO:0043171 (13%);GO:0006310 (6%),methylation (35%);peptide catabolic process (13%);DNA recombination (6%),IPR001261 (18%);IPR002933 (18%);IPR010161 (18%),ArgE/DapE/ACY1/CPG2/YscS, conserved site (18%);Peptidase M20 (18%);Peptidase M20B, tripeptide aminopeptidase (18%)
EVHLFGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%),integral component of membrane (25%),GO:0003677 (75%),DNA binding (75%),GO:0006310 (75%);GO:0015074 (75%);GO:0017004 (25%),DNA recombination (75%);DNA integration (75%);cytochrome complex assembly (25%),IPR002104 (60%);IPR004107 (60%);IPR010998 (60%),Integrase, catalytic domain (60%);Integrase, SAM-like, N-terminal (60%);Integrase/recombinase, N-terminal (60%)
EGLAAANAEAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TASRPLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.1 (50%);2.5.1.141 (50%),Pyruvate dehydrogenase (acetyl-transferring) (50%);Heme o synthase (50%),GO:0016021 (71%);GO:0005739 (14%);GO:0005840 (14%),integral component of membrane (71%);mitochondrion (14%);ribosome (14%),GO:0016758 (43%);GO:0003735 (14%);GO:0004739 (14%),hexosyltransferase activity (43%);structural constituent of ribosome (14%);pyruvate dehydrogenase (acetyl-transferring) activity (14%),GO:0006086 (14%);GO:0006412 (14%);GO:0048034 (14%),acetyl-CoA biosynthetic process from pyruvate (14%);translation (14%);heme O biosynthetic process (14%),IPR018584 (50%);IPR000537 (17%);IPR001017 (17%),Glycosyltransferase family 87 (50%);UbiA prenyltransferase family (17%);Dehydrogenase, E1 component (17%)
TFDSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.10 (18%);2.10.1.1 (13%);2.7.7.75 (13%),Thiazole synthase (18%);Molybdopterin molybdotransferase (13%);Molybdopterin adenylyltransferase (13%),GO:0016021 (18%);GO:0045211 (8%);GO:0034707 (7%),integral component of membrane (18%);postsynaptic membrane (8%);chloride channel complex (7%),GO:0046872 (9%);GO:0005524 (9%);GO:0004888 (8%),metal ion binding (9%);ATP binding (9%);transmembrane signaling receptor activity (8%),GO:0006633 (7%);GO:0019058 (5%);GO:0006364 (5%),fatty acid biosynthetic process (7%);viral life cycle (5%);rRNA processing (5%),IPR016039 (7%);IPR014030 (6%);IPR020841 (6%),Thiolase-like (7%);Beta-ketoacyl synthase, N-terminal (6%);Polyketide synthase, beta-ketoacyl synthase domain (6%)
LPRPAALLVFN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVSFDLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.26 (67%);2.7.7.53 (33%),Prolyl oligopeptidase (67%);ATP adenylyltransferase (33%),GO:0005634 (39%);GO:0016021 (28%),nucleus (39%);integral component of membrane (28%),GO:0003723 (50%);GO:0004252 (11%);GO:0000166 (6%),RNA binding (50%);serine-type endopeptidase activity (11%);nucleotide binding (6%),GO:0005975 (6%),carbohydrate metabolic process (6%),IPR010378 (79%);IPR004087 (9%);IPR004088 (9%),Trafficking protein particle complex subunit 13 (79%);K Homology domain (9%);K Homology domain, type 1 (9%)
LMQLAAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.3.15 (88%);5.6.2.2 (4%);6.1.1.20 (4%),Acetyl-CoA carboxytransferase (88%);DNA topoisomerase (ATP-hydrolyzing) (4%);Phenylalanine--tRNA ligase (4%),GO:0009317 (36%);GO:0016021 (14%);GO:0005886 (12%),acetyl-CoA carboxylase complex (36%);integral component of membrane (14%);plasma membrane (12%),GO:0005524 (44%);GO:0003989 (36%);GO:0016743 (32%),ATP binding (44%);acetyl-CoA carboxylase activity (36%);carboxyl- or carbamoyltransferase activity (32%),GO:0006633 (36%);GO:2001295 (36%);GO:0006265 (2%),fatty acid biosynthetic process (36%);malonyl-CoA biosynthetic process (36%);DNA topological change (2%),IPR001095 (32%);IPR011763 (32%);IPR029045 (32%),Acetyl-CoA carboxylase, alpha subunit (32%);Acetyl-coenzyme A carboxyltransferase, C-terminal (32%);ClpP/crotonase-like domain superfamily (32%)